CSIMarket Company Name, Ticker, Customers, else..


Medicinova Inc   (NASDAQ: MNOV)
Other Ticker:  
 


 

Medicinova Inc

MNOV's Financial Statements and Analysis



Medicinova Inc increased forth quarter of 2024 net loss per share of $-0.06 compare to net loss per share of $-0.04 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.06 realized in previous quarter.


forth quarter of 2024
Earnings Per Share Revenues
$ -0.06 $  0 Mill
$-0.02     Unch.    



Medicinova Inc 's Revenue fell by 0 % in forth quarter of 2024 (Dec 31 2024) year on year, to $0 million and declined by sequentially.


Medicinova Inc is Expected to report next financial results on May 14, 2025.

More on MNOV's Income Statement



Medicinova Inc in the forth quarter of 2024 recorded net loss of $-2.815 million, an increase from net loss of $-2.059 million in IV. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-2.852 million realized in previous quarter.

More on MNOV's Growth

Medicinova Inc Inventories
In Dec 31 2024 company's net cash and cash equivalents decreased by $-2 million


Medicinova Inc does not pay out common stock dividend.

In trailing twelve-month period Medicinova Inc payed $ -0.22 cash per share, on a free-cash flow basis .

Book value fell by -2.66 % sequentially to $1.09 per share, -13.13% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 0.89 per share from $ 0.93.

Company repurchased 1.00 million shares or 2.05 % in Dec 31 2024.


• More on MNOV's Dividends

 Market Capitalization (Millions) 69
 Shares Outstanding (Millions) 48
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -11
 Cash Flow (TTM) (Millions $) -11
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 13




Medicinova Inc does not pay out common stock dividend.

In trailing twelve-month period Medicinova Inc had negative $ -0.22 cash flow per share, on a free-cash flow basis .

Book value fell by -2.66 % sequentially to $1.09 per share, -13.13% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ 0.89 per share from $ 0.93.

Company repurchased 1.00 million shares or 2.05 % in Dec 31 2024.


• More on MNOV's Balance Sheets

 Market Capitalization (Millions) 69
 Shares Outstanding (Millions) 48
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -11
 Cash Flow (TTM) (Millions $) -11
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 13
   


  News about Medicinova Inc Earnings

Medicinova Inc Discloses Impressive Third Quarter Revenue Surpassing $1 Million Milestone

Medicinova Inc, a biopharmaceutical company, recently disclosed impressive financial results for the third quarter of 2023. Despite the prevailing economic challenges faced by many industries, Medicinova Inc managed to achieve a substantial revenue of $1 million during this period. This is a significant improvement compared to the same quarter in the previous year, where the company recorded a net loss of $-0.723 million, a notable reduction from the deficit of $-3.652 million.
These promising financial results demonstrate Medicinova Inc's ability to adapt and thrive in a competitive market. The company's innovative strategies and relentless dedication to research and development have paid off, as eviden...

Medicinova Inc Shows Promising Progress Despite Operating Loss, Sets Stage for Future Success in Pharmaceutical Industry



Medicinova Inc, a major player in the Pharmaceutical Preparations sector, recently released its financial results for the second quarter of 2023. While the company reported an operating loss of $-3.30003 million, it is evident that Medicinova has made significant progress compared to the same period last year, where it recorded an operating loss of $-4.089935 million. This financial improvement positions Medicinova as a potential standout in the competitive Healthcare sector. Let us explore how these financial results may impact the company's future prospects.
1. Reduction in Operating Loss:
The most noteworthy aspect of Medicinova's financial results is the reduction in operating losses. C...

A Closer Look Into Pharmaceutical Industry's Latest Business Developments

The pharmaceutical industry is always on the lookout for the latest business developments and financial performances of companies operating in the sector. One such company is Medicinova Inc, which has recently come under the scanner of industry veterans. The first quarter results for 2023 have been released, and the company has reported an operating loss of $-2.963243 million. What is interesting is that no top-line has been specified by the company so far.
Upon closer inspection, it has been noted that Medicinova Inc has operated more efficiently as compared to the first quarter of 2022, when the operating loss was $-3.410012 million. This indicates that the company is making progress in developing its ...


Date modified: 2025-02-22T04:17:25+00:00





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com